Literature DB >> 32472073

Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Michele Carbone1, Sarah T Arron2, Bruce Beutler3, Angela Bononi4, Webster Cavenee5, James E Cleaver2, Carlo M Croce6, Alan D'Andrea7, William D Foulkes8, Giovanni Gaudino4, Joanna L Groden9, Elizabeth P Henske10, Ian D Hickson11,12, Paul M Hwang13, Richard D Kolodner5, Tak W Mak14, David Malkin15, Raymond J Monnat16,17, Flavia Novelli4, Harvey I Pass18, John H Petrini19, Laura S Schmidt20,21, Haining Yang4.   

Abstract

Cell division and organismal development are exquisitely orchestrated and regulated processes. The dysregulation of the molecular mechanisms underlying these processes may cause cancer, a consequence of cell-intrinsic and/or cell-extrinsic events. Cellular DNA can be damaged by spontaneous hydrolysis, reactive oxygen species, aberrant cellular metabolism or other perturbations that cause DNA damage. Moreover, several environmental factors may damage the DNA, alter cellular metabolism or affect the ability of cells to interact with their microenvironment. While some environmental factors are well established as carcinogens, there remains a large knowledge gap of others owing to the difficulty in identifying them because of the typically long interval between carcinogen exposure and cancer diagnosis. DNA damage increases in cells harbouring mutations that impair their ability to correctly repair the DNA. Tumour predisposition syndromes in which cancers arise at an accelerated rate and in different organs - the equivalent of a sensitized background - provide a unique opportunity to examine how gene-environment interactions influence cancer risk when the initiating genetic defect responsible for malignancy is known. Understanding the molecular processes that are altered by specific germline mutations, environmental exposures and related mechanisms that promote cancer will allow the design of novel and effective preventive and therapeutic strategies.

Entities:  

Mesh:

Year:  2020        PMID: 32472073      PMCID: PMC8104546          DOI: 10.1038/s41568-020-0265-y

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  209 in total

1.  BLM heterozygosity and the risk of colorectal cancer.

Authors:  Stephen B Gruber; Nathan A Ellis; Karen K Scott; Ronit Almog; Prema Kolachana; Joseph D Bonner; Tomas Kirchhoff; Lynn P Tomsho; Khedoudja Nafa; Heather Pierce; Marcelo Low; Jaya Satagopan; Hedy Rennert; Helen Huang; Joel K Greenson; Joanna Groden; Beth Rapaport; Jinru Shia; Stephen Johnson; Peter K Gregersen; Curtis C Harris; Jeff Boyd; Gad Rennert; Kenneth Offit
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

2.  p53 regulates mitochondrial respiration.

Authors:  Satoaki Matoba; Ju-Gyeong Kang; Willmar D Patino; Andrew Wragg; Manfred Boehm; Oksana Gavrilova; Paula J Hurley; Fred Bunz; Paul M Hwang
Journal:  Science       Date:  2006-05-25       Impact factor: 47.728

3.  exo1-Dependent mutator mutations: model system for studying functional interactions in mismatch repair.

Authors:  N S Amin; M N Nguyen; S Oh; R D Kolodner
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Prenatal presentation and outcome of children with pleuropulmonary blastoma.

Authors:  Douglas N Miniati; Murali Chintagumpala; Claire Langston; Megan K Dishop; Oluyinka O Olutoye; Jed G Nuchtern; Darrell L Cass
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

5.  The Fanconi Anemia Pathway in Cancer.

Authors:  Joshi Niraj; Anniina Färkkilä; Alan D D'Andrea
Journal:  Annu Rev Cancer Biol       Date:  2018-12-03

6.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Authors:  Phuong L Mai; Ana F Best; June A Peters; Rosamma M DeCastro; Payal P Khincha; Jennifer T Loud; Renée C Bremer; Philip S Rosenberg; Sharon A Savage
Journal:  Cancer       Date:  2016-08-06       Impact factor: 6.860

7.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

Review 8.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

9.  BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.

Authors:  Michele Carbone; Laura Korb Ferris; Francine Baumann; Andrea Napolitano; Christopher A Lum; Erin G Flores; Giovanni Gaudino; Amy Powers; Peter Bryant-Greenwood; Thomas Krausz; Elizabeth Hyjek; Rachael Tate; Joseph Friedberg; Tracey Weigel; Harvey I Pass; Haining Yang
Journal:  J Transl Med       Date:  2012-08-30       Impact factor: 5.531

10.  Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.

Authors:  Steve Heymann; Suzette Delaloge; Arslane Rahal; Olivier Caron; Thierry Frebourg; Lise Barreau; Corinne Pachet; Marie-Christine Mathieu; Hugo Marsiglia; Céline Bourgier
Journal:  Radiat Oncol       Date:  2010-11-08       Impact factor: 3.481

View more
  29 in total

1.  Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.

Authors:  Lu Wang; Noah Warren Birch; Zibo Zhao; Carson Meredith Nestler; Alexander Kazmer; Anthony Shilati; Alisha Blake; Patrick Alexander Ozark; Emily Jane Rendleman; Didi Zha; Caila Ann Ryan; Marc Alard Jonathan Morgan; Ali Shilatifard
Journal:  Nat Cancer       Date:  2021-05-25

2.  BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.

Authors:  Flavia Novelli; Angela Bononi; Qian Wang; Fang Bai; Simone Patergnani; Franz Kricek; Ellinor Haglund; Joelle S Suarez; Mika Tanji; Ronghui Xu; Yasutaka Takanishi; Michael Minaai; Sandra Pastorino; Paul Morris; Greg Sakamoto; Harvey I Pass; Haithem Barbour; Giovanni Gaudino; Carlotta Giorgi; Paolo Pinton; Jose N Onuchic; Haining Yang; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

Review 3.  Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.

Authors:  Michele Carbone; Harvey I Pass; Guntulu Ak; H Richard Alexander; Paul Baas; Francine Baumann; Andrew M Blakely; Raphael Bueno; Aleksandra Bzura; Giuseppe Cardillo; Jane E Churpek; Irma Dianzani; Assunta De Rienzo; Mitsuru Emi; Salih Emri; Emanuela Felley-Bosco; Dean A Fennell; Raja M Flores; Federica Grosso; Nicholas K Hayward; Mary Hesdorffer; Chuong D Hoang; Peter A Johansson; Hedy L Kindler; Muaiad Kittaneh; Thomas Krausz; Aaron Mansfield; Muzaffer Metintas; Michael Minaai; Luciano Mutti; Maartje Nielsen; Kenneth O'Byrne; Isabelle Opitz; Sandra Pastorino; Francesca Pentimalli; Marc de Perrot; Antonia Pritchard; Robert Taylor Ripley; Bruce Robinson; Valerie Rusch; Emanuela Taioli; Yasutaka Takinishi; Mika Tanji; Anne S Tsao; A Murat Tuncer; Sebastian Walpole; Andrea Wolf; Haining Yang; Yoshie Yoshikawa; Alicia Zolondick; David S Schrump; Raffit Hassan
Journal:  J Thorac Oncol       Date:  2022-04-21       Impact factor: 20.121

4.  Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions.

Authors:  Noriko Hosoya; Kiyoshi Miyagawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 5.  Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).

Authors:  Chiara Diquigiovanni; Elena Bonora
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

Review 6.  Roles of the BAP1 Tumor Suppressor in Cell Metabolism.

Authors:  Anna Han; Timothy J Purwin; Andrew E Aplin
Journal:  Cancer Res       Date:  2021-01-14       Impact factor: 13.312

Review 7.  Emerging multifaceted roles of BAP1 complexes in biological processes.

Authors:  Aileen Patricia Szczepanski; Lu Wang
Journal:  Cell Death Discov       Date:  2021-01-22

Review 8.  Mitochondria and oxygen homeostasis.

Authors:  Mateus P Mori; Rozhin Penjweini; Jay R Knutson; Ping-Yuan Wang; Paul M Hwang
Journal:  FEBS J       Date:  2021-07-08       Impact factor: 5.622

Review 9.  Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.

Authors:  Fabíola Yukiko Miasaki; Cesar Seigi Fuziwara; Gisah Amaral de Carvalho; Edna Teruko Kimura
Journal:  Genes (Basel)       Date:  2020-11-18       Impact factor: 4.096

10.  Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.

Authors:  Jing Chen; Liang Li; Liping Sun; Yuan Yuan; Jingjing Jing
Journal:  PeerJ       Date:  2021-07-15       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.